Twenty-five years ago, the health care system of the Netherlandswas operating under top-down cost-containment policies, suchas regulation of doctors' fees and hospital budgets, that werewidely criticized for lacking incentives for efficiency andinnovation. In 1986, the Dekker Committee, an independent groupappointed by the Dutch government to seek a solution, recommendedmarket-oriented reform within the context of a national healthinsurance system. But before the concept could be implemented,a host of adequate systems had to be developed — systemsof risk equalization, of product classification and medicalpricing to give providers appropriate incentives for efficiency,of . . . [Full Text of this Article]
Source Information
Dr. Enthoven is a professor of management at the Stanford University Graduate School of Business, Stanford, CA. Dr. van de Ven is a professor of health insurance in the Department of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
This article has been cited by other articles:
Westert, G. P, Burgers, J. S, Verkleij, H.
(2009). The Netherlands: regulated competition behind the dykes?. BMJ
339: b3397-b3397
[Full Text]
Rosenau, P. V., Lako, C. J.
(2008). An Experiment with Regulated Competition and Individual Mandates for Universal Health Care: The New Dutch Health Insurance System. Journal of Health Politics, Policy and Law
33: 1031-1055
[Abstract]
Okma, K. G. H.
(2008). Learning and Mislearning across Borders: What Can We (Not) Learn from the 2006 Health Care Reform in the Netherlands? Commentary on Rosenau and Lako. Journal of Health Politics, Policy and Law
33: 1057-1071
Rosenthal, T. C.
(2008). The Medical Home: Growing Evidence to Support a New Approach to Primary Care. J Am Board Fam Med
21: 427-440
[Abstract][Full Text]
Gubb, J.
(2008). Should patients be able to pay top-up fees to receive the treatment they want? Yes. BMJ
336: 1104-1104
[Full Text]
